Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Ams AG    AMS   AT0000A18XM4


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

ams : Spectral Sensing Technology Chosen by Optical Metrology Specialist ELDIM for COVID-19 (SARS-CoV-2) Professional Rapid Testing

11/11/2020 | 11:02am EST

News facts:

  • Rapid test results will be available in 40 minutes and not only limited to a professional healthcare environment
  • Miniaturization of isothermal amplification technology to detect the virus without use of additional equipment
  • ams AS7341L spectral sensor allows reliable spectrally resolved read out of amplified RNA of the virus particles

ams (SIX: AMS), a leading worldwide supplier of high performance sensor solutions, provides the latest sensor technology to ELDIM, a France-based provider of optical metrology technology and related software and hardware design, to support the development of a point of care detection solution for COVID-19 (SARS-CoV-2) using molecular biology and yielding results in professional healthcare environments in only 40 minutes – instead of the previous several hours or days. A specifically developed sensor system based on the ams AS7341L spectral sensor solution allows spectrally resolved read out of amplified RNA of the virus particles, reinforcing ams’ position in delivering high-quality professional health diagnostics.

Optical metrology uses light to set the standards that define units of measurement and for other high-precision research. A team – including Loop Dee Science, a biotech startup focused on point-of-care testing; LRX Technologies, a miniaturized and connected photonic sensors design company; ELDIM, an industrial producer of readers; as well as the University Hospital of Caen Normandy (CHU Caen – Virology department), which is providing scientific input and clinical supervision – has been actively working on the project for several months. All are located in Normandy, France. The resulting solution is the LoopXplore COVID-19 analytical kit and the LoopX, a portable and autonomous professional diagnostics device.

Miniaturization of PCR Testing in Professional Healthcare Environments

PCR (Polymerase Chain Reaction) testing is fundamental to much of the genetic testing underway today and is currently the most frequently used test for COVID-19 (SARS-CoV-2). However, the equipment and expertise needed to use and interpret the data is highly specialized, can be expensive, and is found only in centralized laboratories. In contrast, this new kind of testing from ELDIM and its partners uses isothermal amplification technology to detect the virus itself without bulky equipment. This has the advantage that patients get virtually instanteous and highly accurate feedback on their health status which can avoid the spreading of the virus.

Collaborating to improve COVID-19 medical outcomes

“The high-precision engineering and design of ELDIM, in combination with the technology and clinical input of its partners, plus ams’ highly-performant and sensitive spectral sensors, has resulted in a miniaturized readout which is both faster and more flexible than PCR testing, but without compromising on precision,” said Pascal Philippon, Senior Vice President Sales and Marketing EMEA at ams.

“ELDIM has always focused on supporting new projects with multiple start-ups in various industrial fields. In this important project, we are overseeing the sensor and analytical side of the LoopX solution. Our proven experience in high-end, mass-production processes and manufacturing capabilities will provide healh authorities and future users the best possible quality and reliability,” says Thierry Leroux, President and CEO, ELDIM.

For more information on ams’ AS7341L spectral sensor please go to https://ams.com/AS7341L.

© Business Wire 2020
All news about AMS AG
11:20aAMS : Buy rating from Credit Suisse
11:13aAMS : JP Morgan reiterates its Buy rating
01/25AMS : enables factory productivity and quality with launch of new family of high..
01/14AMS : Barclays reaffirms its Sell rating
01/12AMS : introduces VCSEL IR emitter family for industrial mass market 2/3D sensing
01/11AMS : Introduces World's First AEC-Q102 and ISO 26262 Compliant VCSEL Flood Illu..
01/11AMS : Introduces World's First AEC-Q102 and ISO 26262 Compliant VCSEL Flood Illu..
01/06AMS : AlphaValue/Baader Europe Lifts Price Target on AMS, Downgrades Recommendat..
2020AMS : Precision Biomonitoring Develop Rapid Saliva Antigen Testing for COVID-19
2020AMS : and Precision Biomonitoring announce global partnership to enable pandemic..
More news
Sales 2020 3 382 M 4 112 M 4 112 M
Net income 2020 -43,5 M -52,8 M -52,8 M
Net Debt 2020 2 235 M 2 717 M 2 717 M
P/E ratio 2020 458x
Yield 2020 0,05%
Capitalization 5 199 M 6 314 M 6 321 M
EV / Sales 2020 2,20x
EV / Sales 2021 1,36x
Nbr of Employees 8 609
Free-Float 97,4%
Chart AMS AG
Duration : Period :
ams AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMS AG
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 22,60 €
Last Close Price 18,95 €
Spread / Highest target 56,8%
Spread / Average Target 19,3%
Spread / Lowest Target -36,9%
EPS Revisions
Managers and Directors
Alexander Friedrich Everke Chief Executive Officer
Hans Jörg Kaltenbrunner Chairman-Supervisory Board
Ingo Bank Chief Financial Officer
Thomas Stockmeier Chief Technology Officer
Guido Klestil Honorary Chairman
Sector and Competitors
1st jan.Capitalization (M$)
AMS AG5.68%6 314
BROADCOM INC.6.15%189 036